Medicines Co. (MDCO) Misses Q1 EPS by 20c

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.44), $0.20 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $34.08 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c